Janssen Steps Away from Phase I Prostate Cancer Study, Cites Patient Enrollment Issues

Janssen Steps Away from Phase I Prostate Cancer Study, Cites Patient Enrollment Issues

Submitted by admin on October 31, 2022 - 4:14pm
Source: 
BioSpace
News Tags: 
Essa Pharma
Janssen
JNJ
prostate cancer
clinical trials
EPI-7386
Headline: 
Janssen Steps Away from Phase I Prostate Cancer Study, Cites Patient Enrollment Issues
snippet: 

ESSA Pharma Inc. confirmed in a Monday morning announcement that Janssen has stepped away from a prostate cancer collaboration due to “operational recruitment challenges." 

Do Not Allow Advertisers to Use My Personal information